1 Market Overview of Targeted Drug ROS1 Inhibitors for NSCLC 1.1 Targeted Drug ROS1 Inhibitors for NSCLC Market Overview 1.1.1 Targeted Drug ROS1 Inhibitors for NSCLC Product Scope 1.1.2 Targeted Drug ROS1 Inhibitors for NSCLC Market Status and Outlook 1.2 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region (2016-2027) 1.4 Global Targeted Drug ROS1 Inhibitors for NSCLC Historic Market Size by Region (2016-2021) 1.5 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) 1.6.1 North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) 1.6.2 Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) 1.6.3 Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) 1.6.4 Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) 1.6.5 Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) 2 Targeted Drug ROS1 Inhibitors for NSCLC Market Overview by Type 2.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Targeted Drug ROS1 Inhibitors for NSCLC Historic Market Size by Type (2016-2021) 2.3 Global Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size by Type (2022-2027) 2.4 Crizotinib 2.5 Lorlatinib 2.6 Entrectinib 2.7 Other 3 Targeted Drug ROS1 Inhibitors for NSCLC Market Overview by Application 3.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Targeted Drug ROS1 Inhibitors for NSCLC Historic Market Size by Application (2016-2021) 3.3 Global Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size by Application (2022-2027) 3.4 Squamous Cell Carcinoma of NSCLC 3.5 Adenocarcinoma of NSCLC 3.6 Large Cell Carcinoma of NSCLC 4 Targeted Drug ROS1 Inhibitors for NSCLC Competition Analysis by Players 4.1 Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Targeted Drug ROS1 Inhibitors for NSCLC as of 2020) 4.3 Date of Key Players Enter into Targeted Drug ROS1 Inhibitors for NSCLC Market 4.4 Global Top Players Targeted Drug ROS1 Inhibitors for NSCLC Headquarters and Area Served 4.5 Key Players Targeted Drug ROS1 Inhibitors for NSCLC Product Solution and Service 4.6 Competitive Status 4.6.1 Targeted Drug ROS1 Inhibitors for NSCLC Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Roche 5.1.1 Roche Profile 5.1.2 Roche Main Business 5.1.3 Roche Targeted Drug ROS1 Inhibitors for NSCLC Products, Services and Solutions 5.1.4 Roche Targeted Drug ROS1 Inhibitors for NSCLC Revenue (US$ Million) & (2016-2021) 5.1.5 Roche Recent Developments 5.2 Pfizer 5.2.1 Pfizer Profile 5.2.2 Pfizer Main Business 5.2.3 Pfizer Targeted Drug ROS1 Inhibitors for NSCLC Products, Services and Solutions 5.2.4 Pfizer Targeted Drug ROS1 Inhibitors for NSCLC Revenue (US$ Million) & (2016-2021) 5.2.5 Pfizer Recent Developments 5.3 Beacon Pharma Limited 5.5.1 Beacon Pharma Limited Profile 5.3.2 Beacon Pharma Limited Main Business 5.3.3 Beacon Pharma Limited Targeted Drug ROS1 Inhibitors for NSCLC Products, Services and Solutions 5.3.4 Beacon Pharma Limited Targeted Drug ROS1 Inhibitors for NSCLC Revenue (US$ Million) & (2016-2021) 5.3.5 Drug International Limted Recent Developments 5.4 Drug International Limted 5.4.1 Drug International Limted Profile 5.4.2 Drug International Limted Main Business 5.4.3 Drug International Limted Targeted Drug ROS1 Inhibitors for NSCLC Products, Services and Solutions 5.4.4 Drug International Limted Targeted Drug ROS1 Inhibitors for NSCLC Revenue (US$ Million) & (2016-2021) 5.4.5 Drug International Limted Recent Developments 5.5 Incepta Pharmaceuticals 5.5.1 Incepta Pharmaceuticals Profile 5.5.2 Incepta Pharmaceuticals Main Business 5.5.3 Incepta Pharmaceuticals Targeted Drug ROS1 Inhibitors for NSCLC Products, Services and Solutions 5.5.4 Incepta Pharmaceuticals Targeted Drug ROS1 Inhibitors for NSCLC Revenue (US$ Million) & (2016-2021) 5.5.5 Incepta Pharmaceuticals Recent Developments ... 6 North America 6.1 North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Targeted Drug ROS1 Inhibitors for NSCLC Market Dynamics 11.1 Targeted Drug ROS1 Inhibitors for NSCLC Industry Trends 11.2 Targeted Drug ROS1 Inhibitors for NSCLC Market Drivers 11.3 Targeted Drug ROS1 Inhibitors for NSCLC Market Challenges 11.4 Targeted Drug ROS1 Inhibitors for NSCLC Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Targeted Drug ROS1 Inhibitors for NSCLC Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size Share by Region (2016-2021) Table 4. Global Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size Share by Region (2022-2027) Table 6. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share by Type (2016-2021) Table 9. Global Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share by Type (2022-2027) Table 11. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share by Application (2016-2021) Table 14. Global Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share by Application (2022-2027) Table 16. Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue (US$ Million) by Players (2016-2021) Table 17. Global Targeted Drug ROS1 Inhibitors for NSCLC Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Targeted Drug ROS1 Inhibitors for NSCLC as of 2020) Table 19. Date of Key Manufacturers Enter into Targeted Drug ROS1 Inhibitors for NSCLC Market Table 20. Global Targeted Drug ROS1 Inhibitors for NSCLC Top Players Headquarters and Area Served Table 21. Targeted Drug ROS1 Inhibitors for NSCLC Product Solution and Service Table 22. Global Targeted Drug ROS1 Inhibitors for NSCLC Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Roche Basic Information List Table 25. Roche Description and Business Overview Table 26. Roche Targeted Drug ROS1 Inhibitors for NSCLC Products, Services and Solutions Table 27. Revenue (US$ Million) in Targeted Drug ROS1 Inhibitors for NSCLC Business of Roche (2016-2021) Table 28. Roche Recent Developments Table 29. Pfizer Basic Information List Table 30. Pfizer Description and Business Overview Table 31. Pfizer Targeted Drug ROS1 Inhibitors for NSCLC Products, Services and Solutions Table 32. Revenue (US$ Million) in Targeted Drug ROS1 Inhibitors for NSCLC Business of Pfizer (2016-2021) Table 33. Pfizer Recent Developments Table 34. Beacon Pharma Limited Basic Information List Table 35. Beacon Pharma Limited Description and Business Overview Table 36. Beacon Pharma Limited Targeted Drug ROS1 Inhibitors for NSCLC Products, Services and Solutions Table 37. Revenue (US$ Million) in Targeted Drug ROS1 Inhibitors for NSCLC Business of Beacon Pharma Limited (2016-2021) Table 38. Beacon Pharma Limited Recent Developments Table 39. Drug International Limted Basic Information List Table 40. Drug International Limted Description and Business Overview Table 41. Drug International Limted Targeted Drug ROS1 Inhibitors for NSCLC Products, Services and Solutions Table 42. Revenue (US$ Million) in Targeted Drug ROS1 Inhibitors for NSCLC Business of Drug International Limted (2016-2021) Table 43. Drug International Limted Recent Developments Table 44. Incepta Pharmaceuticals Basic Information List Table 45. Incepta Pharmaceuticals Description and Business Overview Table 46. Incepta Pharmaceuticals Targeted Drug ROS1 Inhibitors for NSCLC Products, Services and Solutions Table 47. Revenue (US$ Million) in Targeted Drug ROS1 Inhibitors for NSCLC Business of Incepta Pharmaceuticals (2016-2021) Table 48. Incepta Pharmaceuticals Recent Developments Table 49. North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2016-2021) & (US$ Million) Table 50. North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2022-2027) & (US$ Million) Table 51. Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2016-2021) & (US$ Million) Table 52. Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2022-2027) & (US$ Million) Table 53. Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region (2016-2021) & (US$ Million) Table 54. Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Region (2022-2027) & (US$ Million) Table 55. Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Region (2016-2021) Table 56. Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Region (2022-2027) Table 57. Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2016-2021) & (US$ Million) Table 58. Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2022-2027) & (US$ Million) Table 59. Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Players (2016-2021) & (US$ Million) Table 60. Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size by Country (2022-2027) & (US$ Million) Table 61. Targeted Drug ROS1 Inhibitors for NSCLC Market Trends Table 62. Targeted Drug ROS1 Inhibitors for NSCLC Market Drivers Table 63. Targeted Drug ROS1 Inhibitors for NSCLC Market Challenges Table 64. Targeted Drug ROS1 Inhibitors for NSCLC Market Restraints Table 65. Research Programs/Design for This Report Table 66. Key Data Information from Secondary Sources Table 67. Key Data Information from Primary Sources List of Figures Figure 1. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Regions: 2021 VS 2027 Figure 4. Global Targeted Drug ROS1 Inhibitors for NSCLC Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Targeted Drug ROS1 Inhibitors for NSCLC Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size Share by Type in 2021 & 2027 Figure 11. Crizotinib Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Lorlatinib Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Entrectinib Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Other Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Global Targeted Drug ROS1 Inhibitors for NSCLC Market Size Share by Application in 2021 & 2027 Figure 16. Squamous Cell Carcinoma of NSCLC Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Adenocarcinoma of NSCLC Market Size (US$ Million) YoY Growth (2016-2027) Figure 18. Large Cell Carcinoma of NSCLC Market Size (US$ Million) YoY Growth (2016-2027) Figure 19. Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 20. Global Top 5 and Top 10 Players Targeted Drug ROS1 Inhibitors for NSCLC Market Share in 2020 Figure 21. North America Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Country (2016-2027) Figure 22. United States Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 23. Canada Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 24. Germany Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 25. France Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 26. U.K. Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 27. Italy Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 28. Russia Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 29. Nordic Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 30. Rest of Europe Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 31. Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Region (2016-2027) Figure 32. China Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 33. Japan Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 34. South Korea Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 35. Southeast Asia Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 36. India Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 37. Australia Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 38. Rest of Asia-Pacific Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 39. Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Country (2016-2027) Figure 40. Mexico Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 41. Brazil Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 42. Rest of Latin America Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 43. Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Share by Country (2016-2027) Figure 44. Turkey Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 45. Saudi Arabia Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 46. UAE Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 47. Rest of Middle East & Africa Targeted Drug ROS1 Inhibitors for NSCLC Market Size (2016-2027) & (US$ Million) Figure 48. Bottom-up and Top-down Approaches for This Report Figure 49. Data Triangulation

Roche Pfizer Beacon Pharma Limited Drug International Limted Incepta Pharmaceuticals